BREO ELLIPTA 100 mcg/25 mcg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BREO ELLIPTA 100 mcg/25 mcg, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma [Phase 3]